Press Releases Achieve Life Sciences, Inc.

Equities

ACHV

US0044685008

Market Closed - Nasdaq Other stock markets 01:30:00 03/05/2024 am IST			5-day change	1st Jan Change
4.69 ^USD	+3.76%		+2.51%	+13.83%

17/04	JonesTrading Starts Achieve Life Sciences With Buy Rating, $20 Price Target	MT
28/03	Transcript : Achieve Life Sciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024	25/04	AQ
Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference	11/04	AQ
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update	29/03	AQ
Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting	20/03	AQ
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024	14/03	AQ
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences	06/03	AQ
Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission	29/02	AQ
Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement	29/02	AQ
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences	12/12	AQ
Achieve Life Sciences Reports Financial Results for Third Quarter and Provides Corporate Update	10/11	AQ
Achieve Life Sciences to Announce Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 9, 2023	26/23/26	AQ
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences	03/23/03	AQ
Achieve Life Sciences Announces Presentation of Cytisinicline E-Cigarette Cessation (ORCA-V1) Results at Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Meeting	11/23/11	AQ
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences	07/23/07	AQ
Achieve Life Sciences Reports Financial Results for Second Quarter 2023 and Provides Corporate Update	15/23/15	AQ
Achieve Life Sciences to Announce Second Quarter 2023 Financial Results and Host Conference Call and Webcast	01/23/01	AQ
Achieve Life Sciences Announces Presentation at 2023 American Society of Pharmacognosy Annual Meeting	18/23/18	AQ
Achieve Life Sciences Announces Publication of Cytisinicline Phase 3 ORCA-2 Smoking Cessation Trial in Journal of the American Medical Association (JAMA)	11/23/11	AQ
ACHIEVE LIFE SCIENCES, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	10/23/10	AQ
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences	06/23/06	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Achieve Life Sciences, Inc.

Equities

ACHV

US0044685008

Press Releases

Filters